Arterial stiffness in chronic kidney disease: causes and consequences.
about
Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysisArterial stiffness, vascular calcification and bone metabolism in chronic kidney diseaseAortic calcification and femoral bone density are independently associated with left ventricular mass in patients with chronic kidney diseaseAnthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3Left ventricular twist mechanics and its relation with aortic stiffness in chronic kidney disease patients without overt cardiovascular disease.Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort studyAssessment of vascular function in patients with chronic kidney disease.Determinants of arterial stiffness in chronic kidney disease stage 3.Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.The association between arterial stiffness and fluid status in peritoneal dialysis patients.Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study.Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease.Measurement of arterial stiffness in subjects with and without renal disease: Are changes in the vessel wall earlier and more sensitive markers of cardiovascular disease than intima media thickness and pulse pressure?Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Modifiable risk factors for increased arterial stiffness in outpatient nephrologyMitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function.Non-invasive measurement of aortic pressure in patients: Comparing pulse wave analysis and applanation tonometry.Modulation of stroke risk in chronic kidney disease.Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes.Cardiovascular effects of sevelamer in stage 3 CKD.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolThe predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function.End Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.Management of Atrial Fibrillation in Patients With Kidney Disease.Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Cardiovascular actions of mineralocorticoid receptor antagonists in patients with chronic kidney disease: A systematic review and meta-analysis of randomized trials.Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.Association of H. pylori infection with chronic kidney disease among Chinese adults.Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease.Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients.Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care.Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry.A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.Central pulse pressure in patients with chronic kidney disease and in renal transplant recipients.
P2860
Q26851216-447BF998-6DAB-40D4-B531-06ABA77BB792Q27024623-FADF5F9C-4049-4383-8F4A-1DB0358463AAQ28728330-9F607491-8E4E-4FC6-8886-A9FCF9B33CCAQ28730621-37D592DD-3436-4635-A006-78FB8426295EQ30388572-87568EF6-6509-425A-B507-66B2A065A513Q30585060-13352B73-14AA-4A20-8DDB-10020AFF8C02Q34130840-23578640-179F-49BF-ABB8-687EE4031B1FQ34207275-24C99BC3-E957-48B6-89F5-38B77ED318EAQ34323504-AF661439-846B-410E-A2E5-09F11F821AD4Q34576578-CFE5F224-8F25-42DB-A01F-1244F59ABAA3Q34602254-3BFA1E91-467A-41C9-8548-1687967A0C5BQ34725189-CC2D581B-AB1E-4D51-AE8F-7653232367B6Q34990456-22FA9018-EDCA-453D-9904-F3E00AE024C6Q35001614-100F8494-9EE6-46F2-91DC-446E5199B4D8Q35071113-26FF09AA-E05B-4DD9-BF3C-9CF8564AFE80Q35121532-9D6DA4EC-17B5-4FB0-ABBA-2898688DF9F9Q35448958-A130CF26-A4EA-44FF-9361-6A4BBFE1D7B4Q35785503-4C7455A9-C7A9-49E5-B8D9-FB5B8534C824Q35890407-FC9FCBCB-574E-4C12-AEC2-FFF09E670F0FQ36482963-5CCA78A3-0CC7-43AB-A1A7-7B752E14EE42Q36625246-55090A7C-D279-4EDE-868D-C504D0FE4B76Q36629673-B9F18DBC-CDAE-456E-BF01-08A9937CAA15Q36796599-C03F8BDE-DCE4-4880-97C5-11EC114FEAB3Q36875566-3A1DA7AF-78F5-4186-BAC7-433D045F2385Q37229608-348DC275-25AF-4877-83DD-226C6A901C9FQ37328492-A257A692-A388-49FB-86FE-8FD84FB31248Q37469045-FB864654-8947-46B0-95F6-4C32603047D1Q37522761-CC979F16-EE5C-4B8D-8F99-3E400A53DB1FQ37877133-424D0DB4-EC11-46A7-B6BE-6E3B336E98CAQ38009044-E1C8F861-2FB8-4B56-8327-153C83D5863EQ38382456-1B3C0832-68AE-4E13-AEC5-F98646E2F6B0Q38758897-1EC49F79-0BDA-47FE-904A-FD596F8B36EDQ39096879-42E5F8FD-0D4A-4CC4-B148-DC5C29432F10Q40387569-2D8816BE-70BC-4A9A-8917-4C013C9ECBFCQ40471430-75A30A2A-6F48-4D60-8B47-D7A40C0EF250Q41353160-0EF5E90B-EE1F-4166-B74A-4BC18B546553Q41513814-00788888-27F2-4CF0-8E6A-CFB59DA56C4DQ41591834-F4521F9F-F2C2-4C4C-98F8-E120DF0B1A1AQ42026773-CF6FB26A-5851-4946-A20B-37D6A01A2EA3Q43860910-14D83B3F-4DC0-4373-8F95-C6A5E0F8D590
P2860
Arterial stiffness in chronic kidney disease: causes and consequences.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Arterial stiffness in chronic kidney disease: causes and consequences.
@en
Arterial stiffness in chronic kidney disease: causes and consequences.
@nl
type
label
Arterial stiffness in chronic kidney disease: causes and consequences.
@en
Arterial stiffness in chronic kidney disease: causes and consequences.
@nl
prefLabel
Arterial stiffness in chronic kidney disease: causes and consequences.
@en
Arterial stiffness in chronic kidney disease: causes and consequences.
@nl
P2093
P356
P1433
P1476
Arterial stiffness in chronic kidney disease: causes and consequences.
@en
P2093
Charles J Ferro
Colin D Chue
Jonathan N Townend
Richard P Steeds
P304
P356
10.1136/HRT.2009.184879
P407
P577
2010-04-20T00:00:00Z